Practical Application of Immuno-Oncology in Renal Cell Carcinoma

Download All
In this online program based on a dynamic CCO symposium from the 2020 ASCO GU symposium, experts discuss the use of immunotherapy in treating patients with RCC. Use the updated irAE decision support tool and download the slides now.
Brian A. Costello, MD, MS
Martin H. Voss, MD


How do you select first-line therapy for your patients with advanced RCC? In this commentary, Drs. Brian A. Costello and Martin H. Voss discuss the latest clinical data on immuno-oncology combinations for frontline therapy in advanced RCC.

Brian A. Costello, MD, MS Martin H. Voss, MD Released: August 18, 2020
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Pfizer and EMD Serono

Supported by a medical education grant from
Exelixis, Inc.
Supported by an independent educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings